The past two years have seen a wide array of scientific discovery and legal issues that affect the development, production, distribution and use of pharmaceuticals, biotechnology products and medical devices as well as ways of providing health services. The field facilitated innovation and regulated risks at record speed. In a conference spanning two days, industry speakers and other legal experts will try to sum up key developments featuring dynamic roundtable sessions, as well as panels covering the following topics across the different sectors of the healthcare and life sciences industry.